[First report on the validity of a continuous Metabolic Syndrome score as an indicator for Metabolic Syndrome in a national sample of paediatric population - the CASPIAN-III study].

CONCLUSION: This nationwide study confirmed the validity of the cMetS score in a population-based sample of Iranian children. cMetSappears to be an appropriate index for investigating the association between potential risk factors and MetS in epidemiological researchin Iran. PMID: 24002955 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24002955?dopt=Abstract

Source: Endokrynologia Polska - September 7, 2013 Category: Endocrinology Authors: Shafiee G, Kelishadi R, Heshmat R, Qorbani M, Motlagh ME, Aminaee T, Ardalan G, Taslimi M, Poursafa P, Larijani B Tags: Endokrynol Pol Source Type: research